十一月 2025
- Home
- Deciphera
十一月 2025的Deciphera市场份额分析
at deciphera, we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work.
Deciphera(包含公司地区分支机构)
查看更多网站流量和参与度信息- deciphera.com
Deciphera收入截至 十一月 2025为 100M - 200M
Deciphera主要域名产生的收入
3 年中Deciphera主要域名的收入
Deciphera主要域名的收入
Deciphera热门域名的总访问量
了解Deciphera市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Deciphera热门域名的平均访问时长
分析Deciphera参与度指标。
过去 3 个月的平均访问时长
子公司明细
Deciphera热门域名的平均页面浏览量
了解Deciphera如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Deciphera 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Deciphera Pharmaceuticals, Inc. attends event 67th American Society of Hematology (ASH) Annual Meeting.Deciphera announces oral presentation of positive topline Results from Phase 2a study of sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting.
十二月 6, 2025阅读更多
新闻Flynn retired from Deciphera Pharmaceuticals, Inc. as president, CEO and chief scientific officer on Dec 8th '23.Flynn recently retired from a 20-year tenure at Deciphera where he was founder and served as president, CEO and chief scientific officer.
一月 8, 2024阅读更多
新闻Deciphera Pharmaceuticals, Inc. recognized as top of the Drug Manufacturers - Specialty & Generic industry.Deciphera Pharmaceuticals Inc (DCPH) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver.
一月 2, 2024阅读更多
查看 Deciphera 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。